. Quality Control in the Endoplasmic Reticulum growing set of integral membrane and soluble proteins-challenges the notion of the ER as a proteolytic Nascent polypeptide chains are translocated across the ER membrane through a pore (green) composed in part of the Sec61p comorganelle and the widely held assumption that translocaplex. Binding of molecular chaperones (red circles) and core tion of proteins into the ER is an irreversible process.
N-glycosylation occur cotranslocationally (step 1). Although several

A Role for the Ubiquitin Proteasome
classes of chaperones participate in folding and translocation, only
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one is shown for simplicity. Polypeptide folding, including the formaThe discovery that lactacystin-a fungal metabolite that tion of disulfide bonds and release from the translocation apparatus, is accompanied by dissociation of molecular chaperones (step 2). specifically binds to and inhibits multiple proteolytic acComplete dissociation from molecular chaperones and competence tivities of the mammalian proteasome (Fenteany et al., for packaging into transport vesicles for export to post-ER compar-1995)-is an effective inhibitor of "ER degradation," ments requires oligomeric assembly (step 3). Mutations or kinetically pointed a long-awaited finger at the proteasome as the slow folding steps retard the release of the nascent chain from culprit in this process. Proteasomes (reviewed by Coux molecular chaperones and, possibly, the translocation apparatus et al., 1996) are cylindrical ring-like assemblies with a (step 2a). Misfolded chains remain associated with molecular chaperones and are prevented from exiting the ER (step 3a).
central chamber into which the proteolytic active site is longer cosediments with membranes. These results suggest a model in which newly synthesized HCs are specifically dislocated from the ER by association with the US11 or US2 proteins to the cytoplasm where they are deglycosylated and then degraded by the proteasome. Unlike CFTR, dislocated HC degradation intermediates that accumulate in US2/US11-expressing cells in the presence of lactacystin are not detectably ubiquitinated. Possibly another tag, perhaps one of the virally Three recent papers now suggest that the cytoplasmic (B) A similar pathway exists for misfolded soluble proteins that are degradation pathway is not restricted to integral memtranslocated into the ER lumen. How these proteins are targeted to brane proteins. In one, Qu et al. (1996) report that the the disolocation apparatus is not known.
degradation of mutant secretory protein ␣ 1 -antitrypsin, which lacks a transmembrane anchor and is therefore the function of two cytoplasmic ubiquitin-conjugating fully translocated into the ER, is inhibited by lactacystin, enzymes, UBC6 and UBC7. The degradation of mutant suggesting the involvement of the proteasome. A secunassembled forms of Sec61p is also blocked by overond paper (Hiller et al., 1996) shows that a mutant form expression of UbK48R and by mutations in PRE1, which of the lumenal vacuolar enzyme carboxypeptidase Y encodes a subunit of the proteasome, further implicating (CPY*), a protein that lacks a transmembrane domain the ubiquitin-proteasome pathway in the process of ER and should thus be fully translocated into the ER ludegradation (Biederer et al., 1996) . men, is degraded by a process requiring the same set The apparent absence of proteasomes from the ER of cytoplasmic ubiquitin-conjugating enzymes (UBC6, lumen poses a topological problem for degradation of UBC7) that are required for Sec61p degradation. Indeed, proteins in the ER, since some or all of these substrates UBC7 was identified by these investigators as DER2, a are segregated from the proteasome by a phospholipid gene required for ER degradation of CPY*. Like CFTR bilayer membrane. However, nearly half of CFTR's and Sec61p, CPY* degradation can be inhibited by coexamino acids are predicted to be exposed to the cytopression of UbK48R. CPY* is also stabilized by mutaplasm and could thus be substrates for ubiquitin-depentions in subunits of the 20S catalytic core (PRE1) or dent proteasomal degradation. What is the fate of the the 19S cap (CIM3) of the proteasome. Similarly, the other half of the protein, which dips into and out of the degradation of a mutant yeast secretory protein, prepro membrane in a serpentine fashion? Does the proteaalpha factor, is sensitive to proteasome mutations in some work like a razor, shaving off only the cytoplasmivivo and to proteasome inhibitors in vitro (Werner et al., cally exposed residues and leaving the membrane and 1996). lumenal portions to another, unidentified protease? Can Unless proteasomes can enter the ER lumen, which the proteasome, known to be a highly processive enhas not been observed, these lumenal proteins must zyme, initiate and terminate degradation in the middle of also be dislocated from the ER for presentation to the a polypeptide chain? Recent data suggest an alternative cytoplasmic ubiquitin-proteasome machinery for degramodel in which ER degradation substrates must be redation. Surprisingly, even though they lack membrane verse translocated or "dislocated" from the ER memanchors, ␣ 1 -antitrypsin, prepro alpha factor, and CPY* brane prior to presentation to the cytoplasmic degradaall remain tightly associated with microsomes following tion apparatus (Figure 2) . disruption of proteasome-inhibited cells, although their Retrograde Translocation of Proteins susceptibility to added extravesicular proteases sugfrom the ER gests that they have been dislocated to the cytosolic One way by which human cytomegalovirus (CMV) side of the ER membrane. This tight association of even evades the host immune system is by inducing the selechydrophilic substrates with the ER membrane suggests tive degradation of newly synthesized class I heavy that dislocation and degradation may be tightly coupled chains (HCs). In cells expressing either of two viral processes. genes, US2 (Wiertz et al., 1996b) or US11 (Wiertz et al., Is Dislocation the Reverse of Translocation? 1996a), HCs are first inserted into the ER membrane and
The notion that the ER membrane participates in the cotranslationally glycosylated but are then degraded by retrograde translocation of proteins is not new. Proteins an extraordinarily rapid (t1/2 Ͻ 1 min) process that is that are unable to complete translocation have been blocked by lactacystin and other proteasome inhibitors.
observed to accumulate at the cytoplasmic side of the Although initially membrane-associated and core-gly-ER membrane as signal peptidase-cleaved intermedicosylated, pulse-chase studies reveal that the HC that ates (Garcia et al., 1988; Nguyen et al., 1991) . Because accumulates in lactacystin-treated cells has been subthe active site of signal peptidase is present at the lumejected to enzymatic deglycosylation, presumably by cytoplasmic N-glycanase (Suzuki et al., 1994) , and no nal side of the ER membrane, these results suggest that at least the early steps of translocation are reversible. What sort of signal sequence directs dislocation substrates to the pore? The simplest model would be if In addition, toxins like ricin or Shiga, which enter the cell through endocytosis, travel in retrograde through misfolded substrates are never fully released from the translocation apparatus. Cross-linking studies suggest the secretory pathway to the ER and must be translocated across the ER membrane to gain access to the that release of integral membrane proteins from the translocation pore proceeds in a stepwise fashion, incytoplasm (Sandvig and van Deurs, 1994) . The mechanism of this translocation is unknown but may involve volving sequential interactions with Sec61p and TRAM and perhaps other components (Do et al., 1996) . Perreversal of the translocation machinery, or perhaps a distinct transport system. haps a signal such as multiubiquitination prevents a misfolded protein from being fully released from the In principle, the same set of general rules that govern the translocation of proteins into the ER (and across translocation apparatus and directs it to the proteasome. Such a situation may well operate for proteins other membranes such as mitochondrial and bacterial inner membranes) should apply to the process of dislolike CFTR that expose large domains to the cytoplasmic ubiquitination apparatus and are rapidly degraded withcation. Thus any dislocation mechanism should satisfy at least the following four criteria. out detectable lag. At the other extreme are secretory proteins like prepro alpha factor, CPY*, and ␣1-antitrypFirst, dislocation substrates should be unfolded or loosely folded. Misfolded proteins that are destined for sin, which, when correctly processed, should be protected from the cytoplasm by the ER membrane. If these dislocation from the ER are associated with ER chaperones like BiP and calnexin, which prevent the formation polypeptides are indeed fully translocated and dissociated from the translocation apparatus, there must be of aggregates on the cis side of the ER membrane and can be envisioned to effectively maintain the proteins an additional signal to direct them to the dislocation and the ubiquitination machinery. The coordination between in a "dislocation competent" state. In CMV-infected cells, the US2 or US11 gene products, which encode the presence of misfolded proteins in the ER and the activation of the cytoplasmic ubiquitin machinery could type I integral membrane proteins could provide such a chaperone function.
involve the IRE1 gene, which encodes a transmembrane kinase that is required for the "unfolded protein reSecond, there should be a source of energy to drive dislocation. On the trans (i.e., cytoplasmic) side of the sponse" in which the presence of unfolded proteins within the ER initiates the transcription of stress remembrane, candidate ATPases that could power dislocation include cytoplasmic HSP70 and the 19S cap of sponse genes in the nucleus (Cox et al., 1993) . Alternatively, retention of proteins in the immediate proximity the proteasome, which possesses intrinsic unfolding ATPase activity. Proteasomes are bound to the cytoof the dislocation-translocation apparatus, possibly mediated by an interaction between molecular chaperones plasmic face of the ER membrane, where they could degrade polypeptides codislocationally. The role of ERand the dislocation apparatus, could eliminate the need for such targeting. bound proteasomes in dislocation and degradation of lumenal and membrane proteins is an important area Finally, how does the quality control machinery discriminate between proteins that are in the process of for future investigation.
Third, there must be a transmembrane pore capable folding and those that are misfolded and should be degraded? Molecular chaperones like BiP and Hsp70 unof engaging dislocating polypeptides and delivering them to the cytoplasmic machinery. The SecY/E protein dergo cycles of ATP-dependent release from substrates; rebinding thus represents a kinetic partition complex, which forms the transmembrane pathway through which exported substrates are translocated between folded and unfolded states. These chaperones bind to folding intermediates and to misfolded proteins across the bacterial inner membrane, can in the absence of proton motive force or association with the peripheral alike, suggesting that their presence or absence from a polypeptide chain cannot be the sole determinant of ATPase component, SecA, facilitate the backwards translocation of substrates (Schiebel et al., 1991) . Can its fate. Some additional signal, possibly ubiquitination, must exist to allow the quality control machinery to evalthe eukaryotic homolog of SecY/E, Sec61p, also function as a bidirectional translocator? Wiertz et al. (1996b) uate the progress of the chaperone interaction and to keep chaperones from cycling indefinitely on nonproreported that in US2-transfected cells treated with lactacystin to block proteolysis, deglycosylated MHC class ductive substrates. Perhaps protein fate is ultimately determined by a three-way kinetic partitioning between I HCs can be coimmunoprecipitated in a complex together with US2 and Sec61p, consistent with the hypothfolding, chaperone binding, and multiubiquitination. Eukaryotic cells have evolved an amazing variety of esis that the Sec61p complex may provide a dislocation pathway across the membrane. Additional studies will editing and quality control systems that monitor the fidelity of key molecular events such as transcription, be needed, however, to confirm whether or not those complexes represent bona fide dislocation intermedireplication, and translation-and protein folding. It is now recognized that aberrant protein folding is an imates, and whether or not additional membrane components are required to form the transmembrane pathway.
portant etiologic factor in the pathogenesis of diseases including cystic fibrosis, ␣ 1 -antitrypsin deficiency, retiniFourth and least well understood, there must be a mechanism by which dislocation substrates are recogtis pigmentosa, Alzheimer's disease, and prion diseases. The finding of a role for the ubiquitin-proteasome nized and delivered to the dislocation apparatus. Most translocation systems require a signal on the substrate pathway in the degradation of proteins that fail to fold productively in the endoplasmic reticulum now adds one protein or on an associated protein that is recognized by a receptor associated with the translocation pore. more function to the rapidly growing list of cellular roles for this versatile system and, for the first time, provides a molecular basis for understanding the quality control systems that operate on proteins in the secretory pathway.
